Results 31 to 40 of about 235,541 (221)

The Role of Steroids in the Management of Macular Edema from Retinal Vein Occlusion

Oftalʹmologiâ, 2019
Aim: To analyze the effectiveness of intravitreal injection of an anti-VEGF agent (ranibizumab) and an dexametazon implant for the intravitreal injection, in real clinical life. Patients and Methods.
M. V. Budzinskaya, A. V. Shelankova, A. A. Plukhova, N. M. Nuriyeva, A. S. Sorokin   +4 more
doaj   +1 more source

Use of intravitreal dexamethasone implant associated or not with antiVEGF therapy in diabetic macular edema: efficacy and safety

Revista Médica de Minas Gerais
Introduction: Diabetic macular edema (DME) is characterized by macular exudation and damage to retinal microvasculature. It is estimated that 30% of diabetic patients develop DME during the course of the disease.
Joice Rodrigues Rachid Amin, Welton Gomes de Paula, Lucas Assis Costa   +2 more
doaj   +1 more source

Intravitreal sustained-release dexamethasone implant for the treatment of persistent cystoid macular edema in ocular syphilis

Indian Journal of Ophthalmology, 2019
With a resurgence of syphilis with human immunodeficiency virus (HIV) infection in last few years, various ocular manifestations of syphilis have been described in literature.
Parthopratim Dutta Majumder, Lakshmi Mayilvakanam, Amit H Palker, Sudharshan Sridharan, Jyotirmay Biswas   +4 more
doaj   +1 more source

Refractory perifoveal exudative vascular anomalous complex like lesion responding to intravitreal dexamethasone implant: A therapeutic challenge

Indian Journal of Ophthalmology. Case Reports, 2022
A 66-year-old male patient presented with the right eye (OD) decreased vision for 1 month duration. His best-corrected visual acuity (BCVA) was 6/36 in OD and 6/6 in the left-eye (OS).
Ashok Nataraj, Jay Sheth, Manoj Soman, Unnikrishnan Nair   +3 more
doaj   +1 more source

Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature [PDF]

, 2014
Matteo Sacchi, Edoardo Villani, Francesca Gilardoni, Paolo Nucci University Eye Clinic, San Giuseppe Hospital, University of Milan, Milan, Italy Background: Macular edema is a known complication even after uneventful cataract surgery.
Villani E, Nucci P, Sacchi M, Gilardoni F, Paolo Nucci, F. Gilardoni, Sacchi, Matteo, Nucci, Paolo, M. Sacchi, E. Villani, Matteo Sacchi, P. Nucci, Gilardoni, Francesca, Edoardo Villani, Francesca Gilardoni, Villani, Edoardo   +15 more
core   +1 more source

Treatment of Intravitreal Ranibizumab Resistant Radiation Retinopathy with Intravitreal Dexamethasone Implant: A Case Report

Beyoglu Eye Journal, 2022
A 43-year-old female patient presented with complaints of decreased vision in both eyes. Her medical history revealed the diagnosis of metastatic breast cancer. She was treated with chemotherapy, and whole-brain, manubrium sterni, and right chest wall radiation therapy. Best-corrected visual acuity (BCVA) was 20/200 and 20/160 in the right and left eye,
Sabaner, Mehmet Cem, Doğan, Mustafa
openaire   +2 more sources

Unilateral intravitreal dexamethasone implant for the treatment of cystoid macular edema in intermediate uveitis

Revista Brasileira de Oftalmologia, 2021
This report aims to describe the effectiveness of a unilateral intravitreal dexamethasone implant (Ozurdex®) used for the treatment of cystoid macular edema in a patient with recurrent intermediate uveitis.
Bruno Boalento dos Santos, Maurélio de Lima Batista Ribeiro Jr, Marcello Novoa Colombo Barboza, Marta Fabiane Gouvea Barioni   +3 more
doaj   +1 more source

Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report

Indian Journal of Ophthalmology, 2012
We report on the significant improvement of central macular thickness in a case of clinically significant macular edema after dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex®; Allergan, Inc, Irvine, CA, USA).
Ashish Sharma, Rangasamy J Madhusudhan, Vidhya Nadahalli, Shreekant A Damgude, Selva K Sundaramoorthy   +4 more
doaj   +1 more source

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®) [PDF]

, 2017
Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion.
Gokhan Demir, Ebru Demet Aygit, Gurkan Erdogan, Irfan Perente, Erdem Eris, Burcin Kepez Yildiz   +5 more
core   +1 more source

Comparative characteristics of the outcomes of the use of multidirectional intravitreal pharmacotherapy in the treatment of diabetic macular edema

Офтальмохирургия, 2021
Purpose. To conduct a comparative analysis of the effectiveness of intravitreal injection of dexamethasone-containing implant and aflibercept in macular edema in patients with diabetes mellitus.Material and methods.
M. M. Bikbov, K. I. Kudoyarova, R. M. Zainullin, T. R. Gilmanshin   +3 more
doaj   +1 more source